When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 03 Jul 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • viral syndrome (prior)
  • autoimmune disease
  • infectious disease
  • drugs and toxins

Other diagnostic factors

  • age <50 years
  • chest pain
  • dyspnoea
  • orthopnoea
  • fatigue
  • palpitations
  • rales
  • elevated neck veins
  • S3 gallop
  • sinus tachycardia
  • atrial and ventricular arrhythmias
  • tachypnoea
  • hepatomegaly
  • syncope
  • fever
  • gastrointestinal issues
  • rhinorrhoea
  • cough
  • S3 and S4 summation gallop
  • pericardial friction rub
  • peripheral hypoperfusion
  • hypotension
  • altered sensorium
  • lymphadenopathy
  • respiratory distress

Risk factors

  • infection (non-HIV)
  • HIV infection
  • autoimmune/immune-mediated diseases
  • peripartum and postnatal periods
  • drugs and toxins

Diagnostic investigations

1st investigations to order

  • 12-lead ECG
  • CXR
  • serum CK
  • serum CK-MB
  • serum troponin (I or T)
  • serum B-type natriuretic peptide
  • two-dimensional echocardiogram
  • 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT)

Investigations to consider

  • endomyocardial biopsy (EMB)
  • coronary angiography
  • cardiac MRI
  • viral polymerase chain reaction (PCR)

Treatment algorithm

Contributors

Authors

Shriprasad R. Deshpande, MBBS, MS

Medical Director

Heart Transplant and Advanced Cardiac Therapies Program

Children's National Hospital

Associate Professor of Pediatrics

The George Washington University

Washington

DC

Disclosures

SRD declares that he has no competing interests.

Bibhuti Das, MBBS, MD, FAAP, FACC

Director of Heart Failure and Heart Transplant

Pediatric Cardiology

University of Mississippi Medical Center

Jackson

MS

Disclosures

BD declares that he has no competing interests.

Acknowledgements

Dr Shriprasad R. Deshpande and Dr Bibhuti Das would like to gratefully acknowledge Dr Katherine C. Wu, Dr James E. Harvey, and Dr Arman T. Askari, previous contributors to this topic. KCW, JEH, and ATA declare that they have no competing interests.

Peer reviewers

David A. Leaf, MD, MPH

Professor of Medicine

School of Medicine

VA Greater Los Angeles Healthcare System

UCLA

Los Angeles

CA

Disclosures

DAL declares that he has no competing interests.

John Charpie, MD, PhD

Associate Professor of Pediatrics

Medical Director

Pediatric Cardiothoracic Intensive Care Unit

University of Michigan Congenital Heart Center

Ann Arbor

MI

Disclosures

JC declares that he has no competing interests.

Lokesh Tejwani, MD, FACC

Assistant Professor of Clinical Medicine

University of Missouri Hospitals and Clinics

Harry S. Truman VA Hospital

Columbia

MO

Disclosures

LT declares that he has no competing interests.

Use of this content is subject to our disclaimer